TORONTO, ONTARIO--(Marketwire - Jan. 30, 2012) - Biosign Technologies Inc. (TSX VENTURE:BIO) ("Biosign") and EasyMed Services Inc. (CNSX:EZM)(OTCBB:EMYSF) ("EasyMed") are pleased to announce they have executed agreements that allow the resale and distribution of each other's respective products as well as a Development and License Agreement for the creation of a joint product offering.
Under the terms of the Agreements:
-- Biosign will have access to resell and distribute EasyMed products
within North America;
-- EasyMed will have access to resell and distribute Biosign products
-- Biosign and EasyMed shall jointly develop new healthcare products and
will share the revenue and intellectual property equally;
-- EasyMed shall become a mobile technology provider for Biosign's future
release of Healthanywhere(TM); and
-- Biosign shall promote the "Powered by EasyMed" brand.
As previously reported, (see news December 5th, 2011), the companies intend to interface UFIT(R) devices into Easy SmartCare and will make the offering available within their respective territories. The combined solution provides benefits for payers, providers, and patients through improved patient preparation for medical visits, decreased absenteeism, better information for both the patient and the caregiver, improved communication of medical results to the patient, and enhanced outpatient management.
"We have found a great partner to address the mobility of our product offering in EasyMed" stated Dr. Scott Jenkins, CEO of Biosign, adding "Together our companies are striving to provide the solutions that enable people to change the way that they manage their health".
Andrew Ritchie, CEO of EasyMed commented, "The partnership between Biosign and EasyMed will allow both companies to strengthen our product offering and take advantage of our strong sales contacts in each of our markets. We also believe that by developing a new product range that takes advantage of both companies existing products and technology, that we will meet a new growing demand by customers to be connected to their healthcare professionals by mobile or internet technology. We are very pleased we were able to conclude the agreements and can now start the process of building a new solution for healthcare".
About EasyMed Services Inc.
EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF) provides mobile healthcare technology solutions that enhance the quality of care for patients and improve healthcare system effectiveness. With EasyMed's mobile platform, caregivers and patients can connect anywhere and anytime to share health information, schedule and confirm visits, access medical records, provide care management for chronic disease, and convey diagnostic results. For more information, visit www.easymedmobile.com.
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSX VENTURE:BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, lifestyle, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT(R) medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit www.biosign.com.
This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. These forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances.The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.